oral glp-1 agonist New Guidelines for Type 2 Diabetes in 2025 Current Insights, Advantages and Challenges

In the SUSTAIN-6 trial, the plot thickens as Ozempics weight loss prowess is revealed

How Long Until Zepbound Starts Working

11 (12):e0168396 61

JAMA (2016) 316(5):5008

The structural similarity of GLP-1 and glucagon as well as of their respective receptors, along with the inherent low-potency promiscuity of these hormones at the other respective receptors (apart from the pancreas, where glucagon has recently been demonstrated to also act on GLP-1R [173]), suggested the possibility of integrating both activities into a sequence-intermixed single molecule hybrid

This narrative review explores the metabolic effects of GLP-1 RAs in weight management, blood glucose, cardiovascular health, lipid profiles, and blood pressure